Literature DB >> 20629049

Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC.

Angela R Filous1, Jared H Miller, Yvette M Coulson-Thomas, Kevin P Horn, Warren J Alilain, Jerry Silver.   

Abstract

Regeneration of injured adult CNS axons is inhibited by formation of a glial scar. Immature astrocytes are able to support robust neurite outgrowth and reduce scarring, therefore, we tested whether these cells would have this effect if transplanted into brain injuries. Utilizing an in vitro spot gradient model that recreates the strongly inhibitory proteoglycan environment of the glial scar we found that, alone, immature, but not mature, astrocytes had a limited ability to form bridges across the most inhibitory outer rim. In turn, the astrocyte bridges could promote adult sensory axon re-growth across the gradient. The use of selective enzyme inhibitors revealed that MMP-2 enables immature astrocytes to cross the proteoglycan rim. The bridge-building process and axon regeneration across the immature glial bridges were greatly enhanced by chondroitinase ABC pretreatment of the spots. We used microlesions in the cingulum of the adult rat brains to test the ability of matrix modification and immature astrocytes to form a bridge for axon regeneration in vivo. Injured axons were visualized via p75 immunolabeling and the extent to which these axons regenerated was quantified. Immature astrocytes coinjected with chondroitinase ABC-induced axonal regeneration beyond the distal edge of the lesion. However, when used alone, neither treatment was capable of promoting axonal regeneration. Our findings indicate that when faced with a minimal lesion, neurons of the basal forebrain can regenerate in the presence of a proper bridge across the lesion and when levels of chondroitin sulfate proteoglycans (CSPGs) in the glial scar are reduced. 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20629049      PMCID: PMC2940988          DOI: 10.1002/dneu.20820

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  94 in total

1.  Sialidase enhances spinal axon outgrowth in vivo.

Authors:  Lynda J S Yang; Ileana Lorenzini; Katarina Vajn; Andrea Mountney; Lawrence P Schramm; Ronald L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

Review 2.  Repair of neural pathways by olfactory ensheathing cells.

Authors:  Geoffrey Raisman; Ying Li
Journal:  Nat Rev Neurosci       Date:  2007-04       Impact factor: 34.870

3.  Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury.

Authors:  Jeff Biernaskie; Joseph S Sparling; Jie Liu; Casey P Shannon; Jason R Plemel; Yuanyun Xie; Freda D Miller; Wolfram Tetzlaff
Journal:  J Neurosci       Date:  2007-09-05       Impact factor: 6.167

4.  Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord.

Authors:  John D Houle; Veronica J Tom; Debra Mayes; Gail Wagoner; Napoleon Phillips; Jerry Silver
Journal:  J Neurosci       Date:  2006-07-12       Impact factor: 6.167

5.  Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury.

Authors:  Jung-Yu C Hsu; Robert McKeon; Staci Goussev; Zena Werb; Jung-Uek Lee; Alpa Trivedi; Linda J Noble-Haeusslein
Journal:  J Neurosci       Date:  2006-09-27       Impact factor: 6.167

6.  Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins.

Authors:  Crystel Ogier; Anne Bernard; Anne-Marie Chollet; Thierry LE Diguardher; Stephen Hanessian; Gérard Charton; Michel Khrestchatisky; Santiago Rivera
Journal:  Glia       Date:  2006-09       Impact factor: 7.452

7.  Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury.

Authors:  Brian K Kwon; Jie Liu; Clarrie Lam; Ward Plunet; Loren W Oschipok; William Hauswirth; Adriana Di Polo; Armin Blesch; Wolfram Tetzlaff
Journal:  Spine (Phila Pa 1976)       Date:  2007-05-15       Impact factor: 3.468

8.  Neuroprotective effect of bone marrow-derived mononuclear cells promoting functional recovery from spinal cord injury.

Authors:  Tomoyuki Yoshihara; Masayoshi Ohta; Yutaka Itokazu; Naoya Matsumoto; Mari Dezawa; Yoshihisa Suzuki; Akihiko Taguchi; Yumi Watanabe; Yasushi Adachi; Susumu Ikehara; Hisashi Sugimoto; Chizuka Ide
Journal:  J Neurotrauma       Date:  2007-06       Impact factor: 5.269

9.  Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo.

Authors:  Paul Lingor; Nicole Teusch; Katrin Schwarz; Reinhold Mueller; Helmut Mack; Mathias Bähr; Bernhard K Mueller
Journal:  J Neurochem       Date:  2007-07-02       Impact factor: 5.372

10.  Astrocytes derived from glial-restricted precursors promote spinal cord repair.

Authors:  Jeannette E Davies; Carol Huang; Christoph Proschel; Mark Noble; Margot Mayer-Proschel; Stephen J A Davies
Journal:  J Biol       Date:  2006-04-27
View more
  41 in total

Review 1.  Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment.

Authors:  M D Howell; P E Gottschall
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

2.  Rebuilding Brain Circuitry with Living Micro-Tissue Engineered Neural Networks.

Authors:  Laura A Struzyna; John A Wolf; Constance J Mietus; Dayo O Adewole; H Isaac Chen; Douglas H Smith; D Kacy Cullen
Journal:  Tissue Eng Part A       Date:  2015-10-23       Impact factor: 3.845

3.  Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes.

Authors:  Nuno J Lamas; Alejandro D Garcia; Laurent Roybon; Eun Ju Yang; Rita Sattler; Vernice J Lewis; Yoon A Kim; C Alan Kachel; Jeffrey D Rothstein; Serge Przedborski; Hynek Wichterle; Christopher E Henderson
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

4.  Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury.

Authors:  Katherine Zukor; Stephane Belin; Chen Wang; Nadia Keelan; Xuhua Wang; Zhigang He
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

5.  Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury.

Authors:  Robin E White; Meghan Rao; John C Gensel; Dana M McTigue; Brian K Kaspar; Lyn B Jakeman
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 6.  CNS repair and axon regeneration: Using genetic variation to determine mechanisms.

Authors:  Andrea Tedeschi; Takao Omura; Michael Costigan
Journal:  Exp Neurol       Date:  2016-05-06       Impact factor: 5.330

7.  Astrocyte phenotypes and their relationship to myelination.

Authors:  Besma Nash; Kalliopi Ioannidou; Susan C Barnett
Journal:  J Anat       Date:  2010-12-24       Impact factor: 2.610

Review 8.  Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia.

Authors:  Jerry Silver; Martin E Schwab; Phillip G Popovich
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-04       Impact factor: 10.005

9.  Noninvasive imaging of nanoparticle-labeled transplant populations within polymer matrices for neural cell therapy.

Authors:  Jacqueline A Tickle; Harish Poptani; Arthur Taylor; Divya M Chari
Journal:  Nanomedicine (Lond)       Date:  2018-06       Impact factor: 5.307

Review 10.  Matrix Metalloproteinases During Axonal Regeneration, a Multifactorial Role from Start to Finish.

Authors:  Lien Andries; Inge Van Hove; Lieve Moons; Lies De Groef
Journal:  Mol Neurobiol       Date:  2016-02-29       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.